Citations

Showing 10 of 108135 citations.

TOP2B Enzymatic Activity on Promoters and Introns Modulates Multiple Oncogenes in Human Gliomas
González-Buendía, Edgar , Zhao, Junfei , Mukherjee, Subhas, Zhang, Daniel Y. , Feldstein, Eric , Kang, Seong Jae , Lee-Chang, Catalina , Mahajan, Aayushi , Chen, Li , Karan, Charles , Magnuson, Lisa, Marshall, Stacy A. , Mohyeldin, Ahmed, Nakano, Ichiro , Bansal, Mukesh , James, C. David , Ahmed, Atique U. , Canoll, Peter , Shilatifard, Ali , Zhang, Daniel , Realubit, Ronald , Karan, Charles , Ahmed, Atique , Sonabend, Adam M , Wang, Lu , Mukherjee, Subhas, Arrieta, Victor Andrés , KANE, JOSHUA ROBERT , Horbinski, Craig , Sarkaria, Jann N. , Brat, Daniel J. , Rabadán, Raúl

Mayo Clinic

Clinical Cancer Research | August 25, 2021 | Volume: 27 | Issue: 20 | Pages: 5669-5680

10.1158/1078-0432.ccr-21-0312 | PMID 34433651 Get It

Abstract Purpose: The epigenetic mechanisms involved in transcriptional regulation leading to malignant phenotype in gliomas remains poorly understood. Topoisomerase IIB (TOP2B), an enzyme that decoils and releases torsional forces in DNA, is overexpressed in a subset of gliomas. Therefore, we investigated its role in epigenetic regulation in these tumors. Experimental Design: To investigate the role of TOP2B in epigenetic regulation in gliomas, we performed paired chromatin immunoprecipitation sequencing for TOP2B and RNA-sequencing analysis of glioma cell lines with and without TOP2B inhibition and in human glioma specimens. These experiments were complemented with assay for transposase-accessible chromatin using sequencing, gene silencing, and mouse xenograft experiments to investigate the function of TOP2B and its role in glioma phenotypes. Results: We discovered that TOP2B modulates transcription of multiple oncogenes in human gliomas. TOP2B regulated transcription only at sites where it was enzymatically active, but not at all native binding sites. In particular, TOP2B activity localized in enhancers, promoters, and introns of PDGFRA and MYC, facilitating their expression. TOP2B levels and genomic localization was associated with PDGFRA and MYC expression across glioma specimens, which was not seen in nontumoral human brain tissue. In vivo, TOP2B knockdown of human glioma intracranial implants prolonged survival and downregulated PDGFRA. Conclusions: Our results indicate that TOP2B activity exerts a pleiotropic role in transcriptional regulation of oncogenes in a subset of gliomas promoting a proliferative phenotype.
RE-MIND: Comparing Tafasitamab + Lenalidomide (L-MIND) with a Real-world Lenalidomide Monotherapy Cohort in Relapsed or Refractory Diffuse Large B-cell Lymphoma
Zinzani, Pier Luigi , Rodgers, Thomas, Marino, Dario , Frezzato, Maurizio, Barbui, Anna Maria, Castellino, Claudia, Meli, Erika, Fowler, Nathan H., Salles, Gilles , Feinberg, Bruce A. , Kurukulasuriya, Nuwan C., Tillmanns, Sascha, Parche, Stephan, Dey, Debarshi, Fingerle-Rowson, Günter, Ambarkhane, Sumeet, Winderlich, Mark, Nowakowski, Grzegorz S., Rodgers, Thomas D. , Feinberg, Bruce , Zinzani, Pier Luigi , Salles, Gilles A , Marino, Dario , Frezzato, Maurizio, Barbui, Anna Maria, Castellino, Claudia, Meli, Erika, Fowler, Nathan H., Kurukulasuriya, Nuwan C., Tillmanns, Sascha, Parche, Stephan, Dey, Debarshi, Fingerle-Rowson, Günter, Ambarkhane, Sumeet, Winderlich, Mark, Nowakowski, Grzegorz S.

Mayo Clinic

Clinical Cancer Research | August 25, 2021 | Volume: 27 | Issue: 22 | Pages: 6124-6134

10.1158/1078-0432.ccr-21-1471 | PMID 34433649 Get It

Abstract Purpose: Tafasitamab, an Fc-modified, humanized, anti-CD19 monoclonal antibody, in combination with lenalidomide, demonstrated efficacy in transplant-ineligible patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL), in the single-arm, phase II L-MIND study (NCT02399085). RE-MIND, a retrospective observational study, generated a historic control for L-MIND to delineate the contribution of tafasitamab to the efficacy of the combination. Patients and Methods: Data were retrospectively collected from patients with R/R DLBCL treated with lenalidomide monotherapy for comparison with tafasitamab + lenalidomide–treated patients (L-MIND). Key eligibility criteria were aligned with L-MIND. Estimated propensity score–based Nearest Neighbor 1:1 Matching methodology balanced the cohorts for nine prespecified prognostic baseline covariates. The primary endpoint was investigator-assessed best overall response rate (ORR). Secondary endpoints included complete response (CR) rate, progression-free survival (PFS), and overall survival (OS). Results: Data from 490 patients going through lenalidomide monotherapy were collected; 140 qualified for matching with the L-MIND cohort. The primary analysis included 76 patients from each cohort who received a lenalidomide starting dose of 25 mg/day. Cohort baseline covariates were comparable. A significantly better ORR of 67.1% (95% confidence interval, 55.4–77.5) was observed for the combination therapy versus 34.2% (23.7–46.0) for lenalidomide monotherapy [odds ratio, 3.89 (1.90–8.14); P < 0.0001]. Higher CR rates were achieved with combination therapy compared with lenalidomide monotherapy [39.5% (28.4–51.4) vs. 13.2% (6.5–22.9)]. Survival endpoints favored combination therapy. Lenalidomide monotherapy outcomes were similar to previously published data. Conclusions: RE-MIND enabled the estimation of the additional treatment effect achieved by combining tafasitamab with lenalidomide in patients with R/R DLBCL.
Brain White Matter Structure and Amyloid Deposition in Black and White Older Adults: The ARIC‐PET Study
Walker, Keenan A. , Hughes, Timothy M. , Jack, Clifford R. , Knopman, David S. , Sharrett, A. Richey , Wong, Dean F. , Mosley, Thomas H. , Mosley, Thomas H. , Knopman, David S. , Hughes, Timothy M , Jack, Clifford R , Gottesman, Rebecca F , Walker, Keenan A , Silverstein, Noah J. , Zhou, Yun , Gottesman, Rebecca F.

Mayo Clinic

Journal of the American Heart Association | August 25, 2021 | Volume: 10 | Issue: 17 | Pages: No page available

10.1161/jaha.121.022087 | PMID 34431373 Get It

Background White matter abnormalities are a common feature of aging and Alzheimer disease, and tend to be more severe among Black individuals. However, the extent to which white matter abnormalities relate to amyloid deposition, a marker of Alzheimer pathology, remains unclear. This cross‐sectional study examined the association of white matter abnormalities with cortical amyloid in a community sample of older adults without dementia and examined the moderating effect of race. Methods and Results Participants from the ARIC‐PET (Atherosclerosis Risk in Communities‐Positron Emission Tomography) study underwent brain magnetic resonance imaging, which quantified white matter hyperintensity volume and microstructural integrity using diffusion tensor imaging. Participants received florbetapir positron emission tomography imaging to measure brain amyloid. Associations between measures of white matter structure and elevated amyloid status were examined using multivariable logistic regression. Among 322 participants (43% Black), each SD increase in white matter hyperintensity volume was associated with a greater odds of elevated amyloid (odds ratio [OR], 1.37; 95% CI, 1.03–1.83) after adjusting for demographic and cardiovascular risk factors. In race‐stratified analyses, a greater white matter hyperintensity volume was more strongly associated with elevated amyloid among Black participants (OR, 2.00; 95% CI, 1.15–3.50), compared with White participants (OR, 1.29; 95% CI, 0.89–1.89). However, the race interaction was not statistically significant ( P interaction=0.09). We found no association between white matter microstructure and elevated amyloid. Conclusions The results suggest a modest positive relationship between white matter hyperintensity and elevated amyloid in older adults without dementia. Although the results indicate that this association is nonsignificantly stronger among Black participants, these findings will need to be confirmed or refuted using larger multiracial cohorts.
Endoscope-Assisted Resection of Extra-Axial Premedullary Neurenteric Cyst via Far Lateral-Supracondylar Approach: 2-Dimensional Operative Video
Vakharia, Kunal , Naylor, Ryan M. , Vakharia, Kunal V., Gompel, Jamie J. Van

Mayo Clinic

Operative Neurosurgery | August 25, 2021 | Volume: 21 | Issue: 6 | Pages: E544-E545

10.1093/ons/opab300 | PMID 34432062 Get It

Abstract Neurenteric cysts are rare congenital lesions that may compress the ventral brainstem. 1-9 In this operative video, we illustrate the surgical treatment of an intradural extra-axial neurenteric cyst extending from the lower pons to the craniocervical junction. The patient, an asymptomatic 52-yr-old female, underwent surveillance imaging of the premedullary lesion for 14 yr without progression. However, after developing progressive strain-induced headaches, imaging revealed a significant enlargement of the lesion with brainstem compression and partial obstruction of the foramen magnum. Therefore, surgical resection was pursued. The patient consented to the procedure. The patient underwent a lateral suboccipital craniotomy and C1 laminectomy through a far lateral approach. The lesion was immediately visualized upon opening the dura. After identifying the cranial nerves, we resected the tumor while taking care to preserve the neurovascular elements of the cerebellopontine angle and foramen magnum. During the resection, we unexpectedly encountered a firm nodule that was adherent to the right posterior inferior cerebellar artery. This was meticulously dissected and removed en bloc using intraoperative indocyanine green (ICG) angiography. The cavity was inspected with 0-degree and 30-degree endoscopes to ensure complete resection of the lesion. Gross total resection was confirmed on postoperative magnetic resonance imaging. The patient was neurologically intact with no cranial nerve abnormalities and discharged home on postoperative day 3. This case demonstrates that the far lateral-supracondylar approach affords safe access to the ventral pontomedullary and craniocervical junctions and that intraoperative adjuncts, including ICG angiography and endoscopic visualization, can facilitate complete lesion resection with excellent clinical outcomes.
Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases
Lindor, Keith D. , Bowlus, Christopher L. , Boyer, James L. , Mayo, Marlyn J. , Boyer, James , Bowlus, Christopher L , Levy, Cynthia

Mayo Clinic

Hepatology | August 24, 2021 | Volume: 75 | Issue: 4 | Pages: 1012-1013

10.1002/hep.32117 | PMID 34431119 Get It

A Universal Approach to Analyzing Transmission Electron Microscopy with ImageJ
Lam, Jacob , Katti, Prasanna , Biete, Michelle , Mungai, Margaret , AshShareef, Salma, Neikirk, Kit , Garza-López, Edgar , Vue, Zer , Christensen, Trace , Beasley, Heather K. , Rodman, Taylor, Murray, Sandra , Salisbury, Jeffrey L., Shao, Jianqiang, Pereira, Renata O. , Abel, E. Dale , Hinton, Antentor , Abel, E Dale , Pereira, Renata O , Hinton, Antentor , Katti, Prasanna , Beasley, Heather K , Murray, Sandra A , Lam, Jacob , Glancy, Brian

Mayo Clinic

Cells | August 24, 2021 | Volume: 10 | Issue: 9 | Pages: 2177

10.3390/cells10092177 | PMID 34571826 Get It

Transmission electron microscopy (TEM) is widely used as an imaging modality to provide high-resolution details of subcellular components within cells and tissues. Mitochondria and endoplasmic reticulum (ER) are organelles of particular interest to those investigating metabolic disorders. A straightforward method for quantifying and characterizing particular aspects of these organelles would be a useful tool. In this protocol, we outline how to accurately assess the morphology of these important subcellular structures using open source software ImageJ, originally developed by the National Institutes of Health (NIH). Specifically, we detail how to obtain mitochondrial length, width, area, and circularity, in addition to assessing cristae morphology and measuring mito/endoplasmic reticulum (ER) interactions. These procedures provide useful tools for quantifying and characterizing key features of sub-cellular morphology, leading to accurate and reproducible measurements and visualizations of mitochondria and ER.
Social and Behavioral Determinants of Health in the Era of Artificial Intelligence with Electronic Health Records: A Scoping Review
Bompelli, Anusha , Wang, Yanshan , Wan, Ruyuan , Singh, Esha, Zhou, Yuqi, Xu, Lin , Oniani, David , Kshatriya, Bhavani Singh Agnikula, Balls‐Berry, Joyce E. , Zhang, Rui , Balls-Berry, Joyce Joy E , Wang, Yanshan , Bompelli, Anusha , Wan, Ruyuan , Singh, Esha, Zhou, Yuqi, Xu, Lin , Oniani, David , Kshatriya, Bhavani Singh Agnikula, Zhang, Rui

Mayo Clinic

Health Data Science | August 24, 2021 | Volume: 2021 | Issue: No issue available | Pages: No page available

10.34133/2021/9759016 | PMID 38487504 Get It

Background . There is growing evidence that social and behavioral determinants of health (SBDH) play a substantial effect in a wide range of health outcomes. Electronic health records (EHRs) have been widely employed to conduct observational studies in the age of artificial intelligence (AI). However, there has been limited review into how to make the most of SBDH information from EHRs using AI approaches. Methods . A systematic search was conducted in six databases to find relevant peer-reviewed publications that had recently been published. Relevance was determined by screening and evaluating the articles. Based on selected relevant studies, a methodological analysis of AI algorithms leveraging SBDH information in EHR data was provided. Results . Our synthesis was driven by an analysis of SBDH categories, the relationship between SBDH and healthcare-related statuses, natural language processing (NLP) approaches for extracting SBDH from clinical notes, and predictive models using SBDH for health outcomes. Discussion . The associations between SBDH and health outcomes are complicated and diverse; several pathways may be involved. Using NLP technology to support the extraction of SBDH and other clinical ideas simplifies the identification and extraction of essential concepts from clinical data, efficiently unlocks unstructured data, and aids in the resolution of unstructured data-related issues. Conclusion . Despite known associations between SBDH and diseases, SBDH factors are rarely investigated as interventions to improve patient outcomes. Gaining knowledge about SBDH and how SBDH data can be collected from EHRs using NLP approaches and predictive models improves the chances of influencing health policy change for patient wellness, ultimately promoting health and health equity.
Outcomes of venetoclax‐based therapy in chronic phase and blast transformed chronic myelomonocytic leukemia
Saliba, Antoine N. , Litzow, Mark R. , Gangat, Naseema , Al‐Kali, Aref , Foran, James M. , Palmer, Jeanne , Mangaonkar, Abhishek A. , Tefferi, Ayalew , Patnaik, Mrinal M. , Saliba, Antoine N. , Palmer, Jeanne M., Mangaonkar, Abhishek A. , Tefferi, Ayalew , Patnaik, Mrinal , Saliba, Antoine N , Saliba, Antoine N , Hogan, William J.

Mayo Clinic

American Journal of Hematology | August 24, 2021 | Volume: 96 | Issue: 11 | Pages: No page available

10.1002/ajh.26334 | PMID 34428328 Get It

Deep learning-based brain age prediction in normal aging and dementia
Lee, Jeyeon , Burkett, Brian J. , Senjem, Matthew L. , Lundt, Emily S. , Botha, Hugo, Graff‐Radford, Jonathan , Barnard, Leland R , Gunter, Jeffrey L. , Schwarz, Christopher G. , Lowe, Val J. , Petersen, Ronald C. , Jones, David, Schwarz, Christopher G , Senjem, Matthew L , Burkett, Brian , Min, Hoon-Ki Paul , Kantarci, Kejal , Knopman, David S. , Boeve, Bradley F. , Jack, Clifford R. , Jones, David, Lundt, Emily S

Mayo Clinic

No container title available | August 24, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-804454/v1 Get It

Abstract Normal brain aging is accompanied by patterns of functional and structural change. Alzheimer's disease (AD), a representative neurodegenerative disease, has been linked to accelerated brain aging at respective age ranges. Here, we developed a deep learning-based brain age prediction model using fluorodeoxyglucose (FDG) PET and structural MRI and tested how the brain age gap relates to degenerative cognitive syndromes including mild cognitive impairment, AD, frontotemporal dementia, and Lewy body dementia. Occlusion analysis, performed to facilitate interpretation of the model, revealed that the model learns an age- and modality-specific pattern of brain aging. The elevated brain age gap in dementia cohorts was highly correlated with the cognitive impairment and AD biomarker. However, regions generating brain age gaps were different for each diagnosis group of which the AD continuum showed similar patterns to normal aging in the CU.
Zero fluoroscopy approach versus fluoroscopy approach for cardiac arrhythmia ablations: A systematic review and meta‐analysis
Kanitsoraphan, Chanavuth , Techorueangwiwat, Chol, Kewcharoen, Jakrin , Ayinapudi, Karnika , Bunch, T. Jared , Groh, Christopher A. , Navaravong, Leenhapong , Kewcharoen, Jakrin , Navaravong, Leenhapong , Kanitsoraphan, Chanavuth , Rattanawong, Pattara

Mayo Clinic

Journal of Cardiovascular Electrophysiology | August 24, 2021 | Volume: 32 | Issue: 10 | Pages: 2761-2776

10.1111/jce.15221 | PMID 34427955 Get It

AbstractBackgroundRadiofrequency catheter ablation for cardiac arrhythmias has traditionally been guided by fluoroscopy. Fluoroscopy exposes the patient, operator, and staff to ionizing radiation which has no safe dose void of stochastic and deterministic biologic risks. Zero fluoroscopy (ZF) approaches for catheter ablation have been advocated to eliminate these risks. We conducted a meta‐analysis comparing acute procedure success, recurrence‐free survival, complications, and procedure times between the approaches.MethodsWe conducted a literature search from inception through December 2020 in the databases of EMBASE and MEDLINE. We included randomized controlled trials and cohorts that compared the outcomes of interest in ZF and conventional/low fluoroscopy (CF/LF) approaches. The outcomes sought were acute procedure success, recurrence‐free survival, complications, and procedure times. Effect estimates were combined, using the random‐effects, generic inverse variance method of DerSimonian and Laird.ResultsSixteen studies from 2013 to 2020, including 6052 patients (2219 ZF, 3833 CF/LF) were included. There were no significant differences in acute procedure success rate (odds ratio [OR]: 1.10, 95% confidence interval [CI]: 0.75–1.59), recurrence‐free survival (OR: 1.08, 95% CI: 0.78–1.49), periprocedural complication rate (OR: 0.72, 95% CI: 0.45–1.16), or total procedure time (weighted mean difference 2.32 min, 95% CI: −2.85–7.50) between ZF and CF/LF approaches, respectively. Overall, only 1.26% of patients crossed over from ZF to CF/LF arm.ConclusionsPeriprocedural and postprocedural outcomes with a ZF approach compared favorably with traditional fluoroscopic guidance without increasing procedural times. As comfort with ZF grows, coupled with evolving mapping technologies, this method has potential to become the standard approach for catheter ablation.